Patents
Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
01/2004
01/14/2004EP1379252A2 Nociceptin analogs
01/14/2004CN1468235A Aminoheterocyclylamides as pesticides and antiparasitic agents
01/14/2004CN1468211A Nitroso diphenylamine derivatives
01/14/2004CN1468207A New retinoids for the treatment of emphysema
01/14/2004CN1134424C Process for making thiadiazol-acetamides derivative using aprotic, aromatic solvent
01/14/2004CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same
01/13/2004US6677360 Biphenyl and biphenyl-analogous compounds as integrin antagonists
01/08/2004WO2004002983A2 Therapeutic piperazine derivatives useful for treating pain
01/08/2004WO2004002977A1 Inhibitors of hcv ns5b polymerase
01/08/2004WO2004002970A1 2,1,3-benzothiadiazoles for use as electronic active components
01/08/2004WO2004002491A1 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors
01/08/2004WO2004002481A1 Aryl carbonyl derivatives as therapeutic agents
01/08/2004WO2004002462A2 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder
01/08/2004WO2003077828A3 Novel florfenicol-type antibiotics
01/08/2004US20040006236 Diaminopropionic acid derivatives
01/08/2004US20040006091 Therapeutic agents useful for treating or preventing pain
01/08/2004US20040006073 Method of treating attention deficit hyperactivity disorder
01/08/2004CA2744893A1 Aryl carbonyl derivatives as glucokinase activators
01/08/2004CA2489433A1 Inhibitors of hcv ns5b polymerase
01/08/2004CA2488566A1 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating attention deficit hyperactivity disorder
01/08/2004CA2488525A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors
01/07/2004EP1377546A2 Process for producing thiosemicarbazides
01/07/2004EP1377263A2 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic diazo dye
01/06/2004US6673820 Aminoheterocyclylamides as pesticides and antiparasitic agents
01/06/2004US6673122 Compositions for dyeing keratin fibers containing para-aminophenols, dyeing process, novel para-aminophenols and process for their preparation
01/02/2004EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals
01/02/2004EP1372655A2 Cathepsin cysteine protease inhibitors
01/01/2004US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device
12/2003
12/31/2003WO2004000797A1 Alpha-sulfonylamino-acetonitriles
12/31/2003WO2004000789A1 Amide linker peroxisome proliferator activated receptor modulators
12/31/2003CN1132819C 作为TNF-α抑制剂的环状肼衍生物 Examples of the cyclic hydrazine derivative TNF-α inhibitors
12/31/2003CA2488972A1 Amide linker peroxisome proliferator activated receptor modulators
12/30/2003US6670385 α-phenyl-βketosulfone
12/25/2003US20030236403 Certain substituted 1-aryl-3-piperazine-1'-yl propanones
12/25/2003US20030236287 Central nervous system disorders; analgesics; antiinflammatory agents; cognition activators; anticancer agents; antidiabetic agents
12/24/2003WO2003106405A1 Aspartyl protease inhibitors
12/24/2003WO2003091232A3 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
12/24/2003CN1463263A Method to inhibit ethylene responses in plants
12/24/2003CN1131855C 1-取代-1-氨基甲基-环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 L-amino-1-substituted methyl - naphthenic derivative (= gabapentin analogs), their preparation and their use in the treatment of neuropathy
12/24/2003CA2489095A1 Aspartyl protease inhibitors
12/23/2003US6667342 Benzenesulfonamide-derivatives and their use as medicaments
12/18/2003WO2003104209A1 Peptide deformylase inhibitors
12/18/2003US20030232939 Control agents for living-type free radical polymerization, methods of polymerizing and polymers with same
12/18/2003US20030232938 Polymerizing mixture of monomers, free radical source and a control agent to produce polymer having thio groups; activating free radical source to generate radicals, wherein thio groups are replaced with group other than hydrogen
12/18/2003US20030232868 Cyclic carboxylic acids as integrin antagonists
12/16/2003CA2122633C 2-heterocyclicethylamine derivatives and their use as pharmaceuticals
12/11/2003WO2003101457A1 Peritoneal dialysis solution with taurolidine
12/11/2003WO2003059876A3 Heterocyclic compounds, combinatorial libraries thereof and methods of selecting drug leads
12/11/2003US20030229054 Novel amines as pharmaceutical agents
12/10/2003EP1369861A2 Optical recording media
12/10/2003EP1368327A1 Benzo thiadiazine matrix metalloproteinase inhibitors
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/09/2003US6660677 Supported group 8-10 transition metal olefin polymerization catalysts
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003028642A3 Methods of inhibiting metastases
12/04/2003US20030225074 E.g., 2-((4'-Methoxy(1,1'-biphenyl)-4-yl)sulfonyl)amino-4-hydroxy-5-((2 -thiazolyl)thio)-pentanoic Acid
12/04/2003US20030225066 Peritoneal dialysis solution with taurolidine
12/02/2003US6656967 Aromatic fungicide compound containing N=C-G group wherein G= O, S, S=O, S(O)2 or N(NRR')
12/02/2003US6656932 Treating osteoarthritis, rheumatoid arthritis, cancer, inflammation, and heart failure
12/02/2003US6656869 Bidentate ligands bonded to nickel, palladium, cobalt, or iron, and optionally, one or more neutral Lewis acids
11/2003
11/27/2003WO2003097047A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003WO2003097045A1 Combination of organic compounds
11/27/2003WO2003014064A8 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
11/27/2003US20030220521 A conjugate compound comprising an antagonist of adrenergic neurotransmitter, and second residue is capable of being cleaved by a kidney enzyme; sodium channel modulators, hypotensive agents
11/27/2003US20030220315 Such as 3',3"-dibromo-4',4"-dimethoxy-5',5"-bis-(methoxycarbonyl)-1,1 -diphenylethene; for treating viral diseases/retroviruses
11/27/2003US20030220268 New phenylalanine derivatives
11/27/2003CA2484233A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/26/2003CN1458143A Process for preparing N-aroyl-L-glutaminic acid
11/25/2003CA2122257C Preparation of substantially dust-free tetrayhdro-3,5- dimethyl-1,3,5-thiadiazine-2-thione granules
11/20/2003WO2003094854A2 Succinoyl aminopyrazoles and related compounds
11/19/2003EP1362041A1 Aryl carbamate derivatives, preparation and use thereof
11/19/2003EP1362028A2 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP1361873A2 Matrix metalloproteinase inhibitors
11/13/2003WO2003093253A1 Alkynyl-substituted spirocyclic sulfamides for the treatment of alzheimer's disease
11/13/2003WO2003093252A1 Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase
11/13/2003WO2003093251A1 Alkenyl-substituted spirocyclic sulfamides as inhibitors of gamma-secretase
11/13/2003WO2003093250A2 Positive allosteric modulators of the nicotinic acetylcholine receptor
11/13/2003WO2003093249A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors
11/13/2003CA2484597A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6645992 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation, and their use
11/11/2003US6645965 Nitrate salts of antihypertensive medicines
11/11/2003CA2133579C Synergistic composition and process for selective weed control
11/06/2003WO2003091232A2 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
11/06/2003WO2003091202A1 Diketohydrazine derivative compounds and drugs contaiing the compounds as the active ingredient
11/06/2003WO2003039539A3 Use of endothelin receptor antagonists in the treatment of tumour diseases
11/06/2003WO2002051983A3 Novel compounds and compositions as cathepsin inhibitors
11/06/2003US20030207880 Heterocycle carboxamides as antiviral agents
11/06/2003US20030207869 Method for controlling pests, characterized in that at least one compound of the formula (I) according to claim 1 or a pesticide according to claim 7 is allowed to act on pests and/ or their habitat.
11/06/2003US20030207864 Novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular
11/06/2003US20030207823 Novel diabetes imaging probes
11/06/2003CA2483155A1 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
11/05/2003EP1357913A1 Heterocyclic inhibitors of glycine transporter 2
11/05/2003CN1126748C Process for producing 2-(methyl sulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
11/04/2003US6641571 Reduction of postoperative complications of cardiopulmonary bypass (CPB) surgery
10/2003
10/30/2003WO2002069901A3 Cathepsin cysteine protease inhibitors
10/30/2003US20030204085 3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists
10/30/2003US20030203945 Coupling a heterocyclic compound containing amine group with a 4-nitrophenyl-1-oxycarbonyl or derivative useful for the treatment of neurological conditions
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 100